Targeting Taspase1 for Cancer Therapy—Letter

We read with interest the article by Chen and colleagues ([1][1]), identifying a potential Taspase1 inhibitor by using a cellular translocation assay similar to the one described by Bier and colleagues ([2][2]). These results impressively underline the power of cell-based screening, as previous